Literature DB >> 10642525

Androctonin, a hydrophilic disulphide-bridged non-haemolytic anti-microbial peptide: a plausible mode of action.

C Hetru1, L Letellier, Z Oren, J A Hoffmann, Y Shai.   

Abstract

Androctonin is a 25-residue non-haemolytic anti-microbial peptide isolated from the scorpion Androctonus australis and contains two disulphide bridges. Androctonin is different from known native anti-microbial peptides, being a relatively hydrophilic and non-amphipathic molecule. This raises the possibility that the target of androctonin might not be the bacterial membrane, shown to be a target for most amphipathic lytic peptides. To shed light on its mode of action on bacteria and its non-haemolytic activity, we synthesized androctonin, its fluorescent derivatives and its all-D-amino acid enantiomer. The enantiomer preserved high activity, suggesting a lipid-peptide interaction between androctonin and bacterial membranes. In Gram-positive and (at higher concentrations) Gram-negative bacteria, androctonin induced an immediate perturbation of the permeability properties of the cytoplasmic membrane of the bacterial energetic state, concomitant with perturbation of the morphology of the cell envelope as revealed by electron microscopy. Androctonin binds only to negatively charged lipid vesicles and induces the leakage of markers at high concentrations and with a slow kinetics, in contrast with amphipathic alpha-helical anti-microbial peptides that bind and permeate negatively charged vesicles, and to a smaller extent also zwitterionic ones. This might explain the selective lytic activity of androctonin towards bacteria but not red blood cells. Polarized attenuated total reflection-Fourier transform infrared spectroscopy revealed that androctonin adopts a beta-sheet structure in membranes and did not affect the lipid acyl chain order, which supports a detergent-like effect. The small size of androctonin, its hydrophilic character and its physicochemical properties are favourable features for its potential application as a replacement for commercially available antibiotics to which bacteria have developed resistance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642525      PMCID: PMC1220801     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

1.  All-D-magainin: chirality, antimicrobial activity and proteolytic resistance.

Authors:  R Bessalle; A Kapitkovsky; A Gorea; I Shalit; M Fridkin
Journal:  FEBS Lett       Date:  1990-11-12       Impact factor: 4.124

2.  A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.

Authors:  M Pritsker; P Jones; R Blumenthal; Y Shai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

3.  The morphological effects of two antimicrobial peptides, hecate-1 and melittin, on Escherichia coli.

Authors:  W G Henk; W J Todd; F M Enright; P S Mitchell
Journal:  Scanning Microsc       Date:  1995-06

4.  Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog.

Authors:  K Matsuzaki; S Yoneyama; N Fujii; K Miyajima; K Yamada; Y Kirino; K Anzai
Journal:  Biochemistry       Date:  1997-08-12       Impact factor: 3.162

5.  Mode of action of an antibacterial peptide, KLKLLLLLKLK-NH2.

Authors:  J Alvarez-Bravo; S Kurata; S Natori
Journal:  J Biochem       Date:  1995-06       Impact factor: 3.387

6.  All-D amino acid-containing channel-forming antibiotic peptides.

Authors:  D Wade; A Boman; B Wåhlin; C M Drain; D Andreu; H G Boman; R B Merrifield
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Channel formation properties of synthetic pardaxin and analogues.

Authors:  Y Shai; D Bach; A Yanovsky
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

8.  Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles.

Authors:  E Gazit; A Boman; H G Boman; Y Shai
Journal:  Biochemistry       Date:  1995-09-12       Impact factor: 3.162

9.  Structural and functional characterization of the alpha 5 segment of Bacillus thuringiensis delta-endotoxin.

Authors:  E Gazit; Y Shai
Journal:  Biochemistry       Date:  1993-04-06       Impact factor: 3.162

10.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more
  10 in total

1.  Implicit Membrane Investigation of the Stability of Antimicrobial Peptide β-Barrels and Arcs.

Authors:  Richard B Lipkin; Themis Lazaridis
Journal:  J Membr Biol       Date:  2014-11-28       Impact factor: 1.843

2.  Antimicrobial peptides and induced membrane curvature: geometry, coordination chemistry, and molecular engineering.

Authors:  Nathan W Schmidt; Gerard C L Wong
Journal:  Curr Opin Solid State Mater Sci       Date:  2013-08       Impact factor: 11.354

3.  Replacement of trifluoroacetic acid with HCl in the hydrophobic purification steps of pediocin PA-1: a structural effect.

Authors:  Hélène Gaussier; Hélène Morency; Marc C Lavoie; Muriel Subirade
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

4.  Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1.

Authors:  Avraham Ashkenazi; Mathias Viard; Linor Unger; Robert Blumenthal; Yechiel Shai
Journal:  FASEB J       Date:  2012-08-07       Impact factor: 5.191

Review 5.  Oncolytic activities of host defense peptides.

Authors:  Sammy Al-Benna; Yechiel Shai; Frank Jacobsen; Lars Steinstraesser
Journal:  Int J Mol Sci       Date:  2011-11-16       Impact factor: 5.923

6.  Structure and Biological Functions of β-Hairpin Antimicrobial Peptides.

Authors:  P V Panteleev; I A Bolosov; S V Balandin; T V Ovchinnikova
Journal:  Acta Naturae       Date:  2015 Jan-Mar       Impact factor: 1.845

7.  Recombinant scorpine produced using SUMO fusion partner in Escherichia coli has the activities against clinically isolated bacteria and inhibits the Plasmodium falciparum parasitemia in vitro.

Authors:  Chao Zhang; Xinlong He; Yaping Gu; Huayun Zhou; Jun Cao; Qi Gao
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

8.  Identification of a novel lytic peptide for the treatment of solid tumours.

Authors:  Rolf Bjerkvig; Lars Prestegarden; Claudia Szczepanski; Olav Tenstad; Anne Baumann; Aurora Martinez; Reidar Myklebust
Journal:  Genes Cancer       Date:  2014-05

9.  Scorpion peptides: potential use for new drug development.

Authors:  Bennasr Hmed; Hammami Turky Serria; Zeghal Khaled Mounir
Journal:  J Toxicol       Date:  2013-06-15

10.  Anti-Salmonella Activity Modulation of Mastoparan V1-A Wasp Venom Toxin-Using Protease Inhibitors, and Its Efficient Production via an Escherichia coli Secretion System.

Authors:  Yeon Jo Ha; Sam Woong Kim; Chae Won Lee; Chang-Hwan Bae; Joo-Hong Yeo; Il-Suk Kim; Sang Wan Gal; Jin Hur; Ho-Kyoung Jung; Min-Ju Kim; Woo Young Bang
Journal:  Toxins (Basel)       Date:  2017-10-13       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.